4
Changes in Ownership
Veradermics, Inc Filed Acc 0001628280-26-057813
Chief Executive Officer sold 67,500 shares at an average $107.86 ($7,280,713)
- Chief Executive Officer acquired 3,452 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Waldman Reid Alexander · Chief Executive Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-17 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,452 | $12.19 | $42,080 | 238,324 | D |
| 2026-08-17 | Sale : show line 2 in the form 10b5-1 | −11,527 | $106.72 | $1,230,161 | 226,797 | D |
| 2026-08-17 | Sale : show line 3 in the form 10b5-1 | −25,234 | $107.53 | $2,713,412 | 201,563 | D |
| 2026-08-17 | Sale : show line 4 in the form 10b5-1 | −27,490 | $108.45 | $2,981,291 | 174,073 | D |
| 2026-08-17 | Sale : show line 5 in the form 10b5-1 | −3,000 | $109.38 | $328,140 | 171,073 | D |
| 2026-08-17 | Sale : show line 6 in the form 10b5-1 | −249 | $111.28 | $27,709 | 170,824 | D |
| Open-market sales · 67,500 sh · avg $107.86 · $7,280,713 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-17 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −3,452 | 0 | D |
Loading xslF345X06/wk-form4_1787101490.xml…